221 related articles for article (PubMed ID: 31403697)
41. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
Hardin H; Montemayor-Garcia C; Lloyd RV
Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
[TBL] [Abstract][Full Text] [Related]
42. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis.
Mytilinaiou M; Nikitovic D; Berdiaki A; Papoutsidakis A; Papachristou DJ; Tsatsakis A; Tzanakakis GN
Exp Cell Res; 2017 Dec; 361(1):9-18. PubMed ID: 28962916
[TBL] [Abstract][Full Text] [Related]
43. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
44. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
45. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
46. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
47. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
48. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
49. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
[TBL] [Abstract][Full Text] [Related]
50. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
51. Epithelial-mesenchymal transition and gastric cancer stem cell.
Xia P; Xu XY
Tumour Biol; 2017 May; 39(5):1010428317698373. PubMed ID: 28459211
[TBL] [Abstract][Full Text] [Related]
52. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
Tabasum S; Singh RP
Chem Biol Interact; 2019 Apr; 303():14-21. PubMed ID: 30802432
[TBL] [Abstract][Full Text] [Related]
53. LIM-kinase is critical for the mesenchymal-to-amoeboid cell morphological transition in 3D matrices.
Mishima T; Naotsuka M; Horita Y; Sato M; Ohashi K; Mizuno K
Biochem Biophys Res Commun; 2010 Feb; 392(4):577-81. PubMed ID: 20100465
[TBL] [Abstract][Full Text] [Related]
54. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
55. The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility.
Lees JG; Bach CT; Bradbury P; Paul A; Gunning PW; O'Neill GM
Oncogene; 2011 Mar; 30(10):1241-51. PubMed ID: 21076470
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of Bmi‑1 promotes epithelial‑mesenchymal transition in CD133+Hep G2 cells.
Zhang Z; Wang Q; Bu X; Zhang C; Chen H; Sha W; Liu W
Mol Med Rep; 2017 Nov; 16(5):6156-6161. PubMed ID: 28849237
[TBL] [Abstract][Full Text] [Related]
57. A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype.
Schwartz MP; Rogers RE; Singh SP; Lee JY; Loveland SG; Koepsel JT; Witze ES; Montanez-Sauri SI; Sung KE; Tokuda EY; Sharma Y; Everhart LM; Nguyen EH; Zaman MH; Beebe DJ; Ahn NG; Murphy WL; Anseth KS
PLoS One; 2013; 8(12):e81689. PubMed ID: 24349113
[TBL] [Abstract][Full Text] [Related]
58. Acquisition of epithelial-mesenchymal transition and cancer stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor spheroids.
Huang YJ; Hsu SH
Biomaterials; 2014 Dec; 35(38):10070-9. PubMed ID: 25282622
[TBL] [Abstract][Full Text] [Related]
59. Quantitative phase imaging unravels new insight into dynamics of mesenchymal and amoeboid cancer cell invasion.
Tolde O; Gandalovičová A; Křížová A; Veselý P; Chmelík R; Rosel D; Brábek J
Sci Rep; 2018 Aug; 8(1):12020. PubMed ID: 30104699
[TBL] [Abstract][Full Text] [Related]
60. How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers.
Alexandrova A; Lomakina M
Front Pharmacol; 2022; 13():962652. PubMed ID: 36278174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
